Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

RecruitingOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

September 28, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

September 15, 2025

Conditions
Hypertension
Interventions
DRUG

Fixed-Dose Combination of Amlodipine/Valsartan

Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertension (high blood pressure). Amlodipine is a calcium channel blocker that works by relaxing the blood vessels, while valsartan is an angiotensin receptor blocker that works by blocking the effects of the hormone angiotensin II, which causes blood vessels to constrict. The combination of amlodipine and valsartan in a single pill has been shown to be more effective in lowering blood pressure than either medication alone. This is because the two medications have different mechanisms of action and work together to provide a more comprehensive approach to blood pressure control.

Trial Locations (2)

Unknown

RECRUITING

Kuwait Teaching Hospital, Peshawar

RECRUITING

National Medical Centre, Karachi

All Listed Sponsors
lead

The Searle Company Limited Pakistan

INDUSTRY